USF2-Mediated APOE-Cholesterol Signaling Promotes CTC Clustering and Metastasis in Non-Small Cell Lung Cancer
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27177821 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Zheng Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Huadong Hospital, Fudan University, Shanghai 200040, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Upstream Stimulatory Factors, Cholesterol. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Municipal Commission of Health and Family Planning, Huadong Hospital, Shanghai Hospital Development Center.
Abstract (Originalsprache)
Circulating tumor cell (CTC) clustering is a key driver of metastatic progression in non-small cell lung cancer (NSCLC), but the underlying molecular mechanisms remain largely unknown. Here, we performed single-cell proteomic sequencing on CTC clusters and individual CTCs isolated from lung cancer patients, identifying 912 proteins in total, of which 246 were significantly upregulated in clusters versus single CTCs. Enrichment analyses revealed a prominent involvement of lipid and cholesterol metabolism pathways. Apolipoprotein E (APOE) emerged as a central hub, exhibiting marked upregulation in CTC clusters. Functional experiments showed that cholesterol supplementation promoted cluster formation in NSCLC cell lines and accelerated metastatic dissemination in vivo, whereas APOE depletion impaired clustering capacity. Mechanistically, we identified USF2 as a potential transcriptional regulator of APOE through direct binding to the promoter, as supported by Chromatin Immunoprecipitation (ChIP) and reporter assays. Clinical validation in a cohort of 75 lung cancer patients demonstrated that elevated APOE expression was strongly associated with advanced pathological grade, distant metastasis, and poor survival. Taken together, these findings establish a novel USF2–APOE–cholesterol axis that governs CTC clustering and metastatic progression, positioning APOE as both a prognostic biomarker and a potential therapeutic target for NSCLC metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Huadong Hospital, Fudan University, Shanghai 200040, China.
- Department of Pharmacy, Huadong Hospital, Fudan University, Shanghai 200040, China.
- Department of Radiation Oncology, Huadong Hospital, Fudan University, Shanghai 200040, China.
ORCID-Profile: Li Sun
Förderung
- Shanghai Municipal Commission of Health and Family Planning
- Huadong Hospital
- Shanghai Hospital Development Center
- Shanghai Municipal Health Commission
- National Natural Science Foundation of China Young Scientists Fund Cultivation Project
- National Natural Science Foundation of China General Program
Zitieren
APA
Li, Z., Cui, M., Sun, L., Qin, H., Shen, X., & Gao, W. (2026). USF2-Mediated APOE-Cholesterol Signaling Promotes CTC Clustering and Metastasis in Non-Small Cell Lung Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27177821
Vancouver
Li Z, Cui M, Sun L, Qin H, Shen X, Gao W. USF2-Mediated APOE-Cholesterol Signaling Promotes CTC Clustering and Metastasis in Non-Small Cell Lung Cancer. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27177821
BibTeX
@article{Li2026,
author = {Li, Zheng and Cui, Meng and Sun, Li and Qin, Hao and Shen, Xiaoyong and Gao, Wen},
title = {USF2-Mediated APOE-Cholesterol Signaling Promotes CTC Clustering and Metastasis in Non-Small Cell Lung Cancer},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27177821}
}
EUVIMED